Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate to prevent contrast-induced nephropathy in CTPA
2009-013547-11Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium bicarbonate in contrast-induced nephropathy (CIN) and Postcontrast Acute Kidney Injury (PC-AKI) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Mean increase in serum creatinine 2–4 days after CTPA and Incidence of contrast-induced nephropathy after CTPA. Started Jul 2009; status: active.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)Postcontrast Acute Kidney Injury (PC-AKI)
Beyond the preview
Go deeper on 2009-013547-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013547-11.